The $106 million research hub will support cross-institutional projects built on the following scientific “pillars:” imaging, engineering, genomics, molecular therapeutics and computation and data analytics.
“The gains in knowledge amassed by neuroscientists over the past few decades can now be brought to the next level with supercomputers, electronic brain–computer interfaces, nanotechnology, robotics and powerful imaging tools,” said philanthropist Sanford I. Weill, chairman of the Weill Family Foundation, which donated the funds for the new Weill Neurohub.
Using artificial intelligence and supercomputing abilities, the Weill Neurohub will provide funding for faculty, postdoctoral fellows and graduate students at UCSF, UC Berkeley and UW to work on cross-disciplinary projects to advance the study of traumatic brain injury and neurodegenerative diseases. Current neuroscience projects underway at the organization include customized neurotherapies based on CRISPR gene-targeting system and AI applications that can detect life-threatening hemorrhages in CT scans of the brain.
More articles on innovation:
Inspira Health unveils tech for EHR, health innovation at new hospital
3 tips to engage physicians in innovation: HBR
U of Arizona unveils medical simulation center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
